L’OREAL - H1 FIRST TAKE - Q2 LFL Ahead

Research evidence excerpt

L’OREAL - H1 FIRST TAKE - Q2 LFL Ahead

organ group receives.

MAR Disclosure site: https://markets.jpmorgan.com/#disclosures.Market_Abuse_Regime

Access to any conference calls, meetings or events linked above will be, where relevant, subject to availability. These events are not suitable for retail clients but are intended for professional and

institutional clients only. Equally, these events are not accessible to J.P. Morgan corporate clients, including their management teams and investor relations contacts. Some of the events referenced above

will only be available to and can only be attended by High Touch clients who have subscribed to certain J.P. Morgan research packages. Any research analyst meetings will be charged for in accordance

with the research pricing we have agreed with you.

All materials and information shared with you are, unless otherwise indicated to you, proprietary and confidential to J.P. Morgan. You are hereby notified that any disclosure, dissemination, copying,

distribution, or use of the information provided to you, in whole or in part, other than as expressly permitted by J.P. Morgan, is STRICTLY PROHIBITED. You are permitted to disclose the materials and

information to your officers and employees on a need to know basis.

If you consider the facilitation component of any of these events to be a non-monetary benefit, please contact your normal J.P. Morgan sales advisor to discuss making a payment for this service which is

unbundled from any research payment. The event is intended for J.P. Morgan clients only.

If you have any questions in this regard, please contact your normal J.P. Morgan representative.

For further information in respect of non-research content please visit: https://www.jpmorgan.com/pages/disclosures/materialdisclaimer.